Craft

Merck Group

Stock Price

€155.4

2024-05-10

Market Capitalization

€67.6 B

2024-05-10

Revenue

€21 B

FY, 2023

Merck Group Summary

Company Summary

Overview
Merck Group is a science and technology company. It operates in three business segments: Life Science, Healthcare, and Electronics. The Life Science segment provides filtration devices, chromatography resins, processing chemicals, monoclonal antibodies, active pharmaceutical ingredients, reagents, consumables, devices, and other products and services for academic labs, biotech and pharmaceutical companies, diagnostics labs, and the industrial sector. The Healthcare segment develops and manufactures pharmaceutical and biological drugs for oncology, neurology, immunology, fertility, cardiology, endocrinology, and other healthcare branches. The Electronics segment offers materials and solutions for the semiconductor and display industries.
Type
Public
Status
Active
Founded
1668
HQ
Darmstadt, DE | view all locations
Website
https://www.merckgroup.com/en
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Belén Garijo

    Belén Garijo, Chair of the Executive Board and CEO

  • Kai Beckmann

    Kai Beckmann, Member of the Executive Board, CEO Electronics

  • Peter Guenter

    Peter Guenter, Member of the Executive Board, CEO Healthcare

  • Matthias Heinzel

    Matthias Heinzel, Member of the Executive Board, CEO Life Science

Operating MetricsView all

Scientists and Researchers

8.3K
5.1%

FY, 2021

Major Product Lines (Neurology and Immunology)

2

FY, 2021

Major Product Lines (General Medicine and Endocrinology)

4

FY, 2021

LocationsView all

124 locations detected

  • Darmstadt, HE HQ

    Germany

    Frankfurter Str. 250

  • San Jose, CA

    United States

    3011 N 1st St

  • Buenos Aires, CABA

    Argentina

    Tronador 4890, 4° piso

  • Bayswater, VIC

    Australia

    Ground Floor, Building 1/885 Mountain Hwy

  • Macquarie Park, NSW

    Australia

    Suite 1, Level 1, Building B/11 Talavera Rd

  • Wien, Wien

    Austria

    Zimbagasse 5

and 118 others

Merck Group Financials

Summary Financials

Revenue (FY, 2023)
€21.0B
Gross profit (FY, 2023)
€13.9B
Net income (FY, 2023)
€2.8B
Cash (FY, 2023)
€2.0B
EBIT (FY, 2023)
€3.6B
Enterprise value
$75.5B

Footer menu